FDA postpones advisory panel meeting on Pfizer COVID vaccine for young kids
(CNN) — The US Food and Drug Administration announced Friday that it is postponing the meeting of its Vaccines and Related Biological Products Advisory Committee, originally scheduled for February 15, as “new data have recently emerged” regarding Pfizer and BioNTech’s emergency use authorization request for their Covid-19 vaccine for children younger than 5.
“This will give the agency time to consider the additional data, allowing for a transparent public discussion as part of our usual scientific and regulatory processes for COVID-19 vaccines. We will provide an update on timing for the advisory committee meeting once we receive additional data on a third dose in this age group from the company’s ongoing clinical trial and have an opportunity to complete an updated evaluation,” acting FDA Commissioner Dr. Janet Woodcock and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.
This is a developing story and will be updated.
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
Today’s Top Stories
- Eviction filings on the rise in Utah, compared to this time last year
- At Alpine school board meeting, Natalie Cline claims district allows porn in classrooms
- Ballpark Station reopens after closing due to fallen scaffolding
- Crash involving RV leaves one dead
- Automatic emergency braking should only be used as a last resort
- Home improvement tip: Increase the value of your home by weatherproofing doors
- Teen killed in Hurricane auto-pedestrian accident
- How facial plastic surgery and skincare are joining forces
- 21-year-old man sentenced for multiple sex crimes
- BYU engineering students put ‘world’s smallest Book of Mormon’ on 4 inch disc